at 0.5 mm butyric acid , inhibition of cml progenitors , both from chronic phase and blastic phase patients , was significantly greater ( p less than 0.01 ) than bone marrow from non-leukemic patients and peripheral blood controls .
C0005699
blastic phase
C0005953
bone marrow